Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh

During 1989–2002, we studied the antimicrobial resistance of 3928 blood culture isolates of Salmonella enterica serotype Typhi (S. Typhi) in Dhaka, Bangladesh. Overall 32% (1270) of the strains were multidrug-resistant (MDR, resistant to chloramphenicol, ampicillin and trimethoprim–sulphamethoxazole...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiology and infection 2006-04, Vol.134 (2), p.433-438
Main Authors: RAHMAN, M., SIDDIQUE, A. K., SHOMA, S., RASHID, H., SALAM, M. A., AHMED, Q. S., NAIR, G. B., BREIMAN, R. F.
Format: Article
Language:English
Subjects:
Anti-Infective Agents - pharmacology
Antimicrobials
Bacteriology
Bangladesh - epidemiology
Biological and medical sciences
Blood
Ciprofloxacin - pharmacology
Disease Outbreaks
Drug Resistance, Multiple
Epidemics
Fundamental and applied biological sciences. Psychology
Humans
Infections
Medical treatment failures
Microbial Sensitivity Tests
Microbiology
Miscellaneous
Physicians
Salmonella
Salmonella enterica
Salmonella typhi
Salmonella typhi - drug effects
Salmonella typhi - pathogenicity
Typhoid
Typhoid fever
Typhoid Fever - drug therapy
Typhoid Fever - epidemiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During 1989–2002, we studied the antimicrobial resistance of 3928 blood culture isolates of Salmonella enterica serotype Typhi (S. Typhi) in Dhaka, Bangladesh. Overall 32% (1270) of the strains were multidrug-resistant (MDR, resistant to chloramphenicol, ampicillin and trimethoprim–sulphamethoxazole); first detected in 1990 (rate of 8%), increased in 1994 (44%), declined in 1996 (22%, P
ISSN:0950-2688
1469-4409
DOI:10.1017/S0950268805004759